Implementation of Shared Decision-Making in Cancer Care (PREPARED)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03393351 |
|
Recruitment Status :
Completed
First Posted : January 8, 2018
Last Update Posted : June 4, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Cancer | Other: Shared decision-making program Other: Usual Care | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 2131 participants |
| Allocation: | Randomized |
| Intervention Model: | Sequential Assignment |
| Intervention Model Description: | A stepped wedge design, a variant of the cluster randomized controlled trial feasible to evaluate interventions in routine implementation, will be used. Participating clinics will receive the multifaceted implementation program in a randomized sequence. |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Evaluation of a Program for Routine Implementation of Shared Decision-Making in Cancer Care: A Stepped Wedge Cluster Randomized Trial |
| Actual Study Start Date : | March 5, 2018 |
| Actual Primary Completion Date : | September 12, 2020 |
| Actual Study Completion Date : | December 31, 2020 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: Shared decision-making program |
Other: Shared decision-making program
The intervention is shared decision-making. The implementation strategy to foster shared decision-making in routine cancer care is a multicomponent implementation program. The implementation program consists of the following components:
Implementation: after baseline assessment (t0) for clinic 1, after assessment at t1 for clinic 2, after assessment at t2 for clinic 3. |
| Active Comparator: Usual care |
Other: Usual Care
No specific study related intervention. Treatment decisions are made according to current routine practice at the comprehensive cancer center in Germany. |
- Change in uptake of shared decision-making from the patients' perspective [ Time Frame: All clinics: baseline, 8 months, 16 months, 24 months ]Action to employ shared decision-making as measured by the German version of the 9-item Shared Decision Making Questionnaire (SDM-Q-9)
- Change in uptake of shared decision-making from external observers' perspective [ Time Frame: All clinics: baseline, 8 months, 16 months, 24 months ]Action to employ shared decision-making as measured by the German version of the Observer OPTION 5 scale using audio-recorded medical encounters. The Observer OPTION 5 scale measures the extent to which clinicians involve patients in decision-making. Each of the 5 items is assessed on a scale ranging from 0 to 4 with higher values indicating more involvement of patients in decision-making. A sum score is calculated (ranging from 0 to 20) and rescaled to be between 0 to 100, for ease of interpretation.
- Acceptability of shared decision-making from the health care providers' perspective [ Time Frame: All clinics: baseline, 8 months, 16 months, 24 months ]Perception that shared decision-making is agreeable, palatable, or satisfactory as measured by an adapted version of the acceptability survey developed by McColl et al.
- Readiness for implementing change from the health care professionals' perspective [ Time Frame: All clinics: baseline, 8 months, 16 months, 24 months ]As measured by an adapted version of the Organizational Readiness for Implementing Change (ORIC) measure
- Appropriateness of shared decision-making from the health care professionals' perspective [ Time Frame: All clinics: baseline, 8 months, 16 months, 24 months ]Perceived fit, relevance, or compatibility of shared decision-making for the given practice setting as measured by an adapted version of the IcanSDM measure
- Change in penetration of shared decision-making at the clinic level [ Time Frame: baseline, 3 years ]Integration of shared decision-making within a setting and its subsystems as measured by routine data from patient experience surveys of the clinics
- Change in penetration of shared decision-making in multidisciplinary team meetings [ Time Frame: All clinics: baseline, 8 months, 16 months, 24 months ]Integration of shared decision-making within a setting and its subsystems as measured by an adapted version of the Metric for the Observation of Decision Making in Multidisciplinary Team Meetings (MDT-MODe)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria for participating patients:
- diagnosed with neoplasms (ICD 10: C00-D49, excluding D10-D36)
- admitted for inpatient or outpatient treatment at the participating clinics
- age > 18 years
- German-speaking
Exclusion Criteria for participating patients:
- severe cognitive impairment
Inclusion Criteria for participating health care professionals:
- physician or nurse working at the participating clinics
Exclusion Criteria for participating health care professionals:
- none
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03393351
| Germany | |
| University Medical Center Hamburg-Eppendorf, Center for Oncology, II. Medical Clinic and Polyclinic | |
| Hamburg, Germany | |
| University Medical Center Hamburg-Eppendorf, Center for Surgical Sciences, Department of Gynecology | |
| Hamburg, Germany | |
| University Medical Center Hamburg-Eppendorf, Head and Neurocenter, Department of Oral and Maxillofacial Surgery | |
| Hamburg, Germany | |
| Principal Investigator: | Isabelle Scholl, Dr. | Universitätsklinikum Hamburg-Eppendorf |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Isabelle Scholl, Head of Research Group, Prinicipal Investigator, Universitätsklinikum Hamburg-Eppendorf |
| ClinicalTrials.gov Identifier: | NCT03393351 |
| Other Study ID Numbers: |
SCHO 1551/1-2 |
| First Posted: | January 8, 2018 Key Record Dates |
| Last Update Posted: | June 4, 2021 |
| Last Verified: | June 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Shared Decision-Making Decision Making Patient Participation Patient Centeredness Health Services Research |
Implementation Research Oncology Stepped Wedge Design Mixed Methods |

